These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 11842257)

  • 41. Structural characterization of the fusion-active complex of severe acute respiratory syndrome (SARS) coronavirus.
    Ingallinella P; Bianchi E; Finotto M; Cantoni G; Eckert DM; Supekar VM; Bruckmann C; Carfi A; Pessi A
    Proc Natl Acad Sci U S A; 2004 Jun; 101(23):8709-14. PubMed ID: 15161975
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Design and characterization of human respiratory syncytial virus entry inhibitors.
    Ni L; Zhao L; Qian Y; Zhu J; Jin Z; Chen YW; Tien P; Gao GF
    Antivir Ther; 2005; 10(7):833-40. PubMed ID: 16312179
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Crystal structures of Nipah and Hendra virus fusion core proteins.
    Lou Z; Xu Y; Xiang K; Su N; Qin L; Li X; Gao GF; Bartlam M; Rao Z
    FEBS J; 2006 Oct; 273(19):4538-47. PubMed ID: 16972940
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Identification of a Novel Inhibitor against Middle East Respiratory Syndrome Coronavirus.
    Sun Y; Zhang H; Shi J; Zhang Z; Gong R
    Viruses; 2017 Sep; 9(9):. PubMed ID: 28906430
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Cloning and expression of heptad repeat regions of the Newcastle disease virus fusion protein].
    Liu YF; Yu M; Wang EX; Tian B
    Sheng Wu Gong Cheng Xue Bao; 2001 Nov; 17(6):631-4. PubMed ID: 11910754
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Peptides corresponding to the heptad repeat sequence of human parainfluenza virus fusion protein are potent inhibitors of virus infection.
    Yao Q; Compans RW
    Virology; 1996 Sep; 223(1):103-12. PubMed ID: 8806544
    [TBL] [Abstract][Full Text] [Related]  

  • 47. The C34 Peptide Fusion Inhibitor Binds to the Six-Helix Bundle Core Domain of HIV-1 gp41 by Displacement of the C-Terminal Helical Repeat Region.
    Louis JM; Baber JL; Clore GM
    Biochemistry; 2015 Nov; 54(45):6796-805. PubMed ID: 26506247
    [TBL] [Abstract][Full Text] [Related]  

  • 48. The core of the respiratory syncytial virus fusion protein is a trimeric coiled coil.
    Matthews JM; Young TF; Tucker SP; Mackay JP
    J Virol; 2000 Jul; 74(13):5911-20. PubMed ID: 10846072
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Carbohydrate modifications of the NDV fusion protein heptad repeat domains influence maturation and fusion activity.
    McGinnes L; Sergel T; Reitter J; Morrison T
    Virology; 2001 May; 283(2):332-42. PubMed ID: 11336558
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Role of the simian virus 5 fusion protein N-terminal coiled-coil domain in folding and promotion of membrane fusion.
    West DS; Sheehan MS; Segeleon PK; Dutch RE
    J Virol; 2005 Feb; 79(3):1543-51. PubMed ID: 15650180
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Newcastle disease virus HN protein alters the conformation of the F protein at cell surfaces.
    McGinnes LW; Gravel K; Morrison TG
    J Virol; 2002 Dec; 76(24):12622-33. PubMed ID: 12438588
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Characterization of HCoV-229E fusion core: implications for structure basis of coronavirus membrane fusion.
    Liu C; Feng Y; Gao F; Zhang Q; Wang M
    Biochem Biophys Res Commun; 2006 Jul; 345(3):1108-15. PubMed ID: 16714001
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Effects of ectodomain sequences between HR1 and HR2 of F1 protein on the specific membrane fusion in paramyxoviruses.
    Ren G; Wang Z; Hu X
    Intervirology; 2007; 50(2):115-22. PubMed ID: 17191013
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Fusion core structure of the severe acute respiratory syndrome coronavirus (SARS-CoV): in search of potent SARS-CoV entry inhibitors.
    Chu LH; Chan SH; Tsai SN; Wang Y; Cheng CH; Wong KB; Waye MM; Ngai SM
    J Cell Biochem; 2008 Aug; 104(6):2335-47. PubMed ID: 18442051
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Structural characterization of the human respiratory syncytial virus fusion protein core.
    Zhao X; Singh M; Malashkevich VN; Kim PS
    Proc Natl Acad Sci U S A; 2000 Dec; 97(26):14172-7. PubMed ID: 11106388
    [TBL] [Abstract][Full Text] [Related]  

  • 56. The stability of the intact envelope glycoproteins is a major determinant of sensitivity of HIV/SIV to peptidic fusion inhibitors.
    Gallo SA; Sackett K; Rawat SS; Shai Y; Blumenthal R
    J Mol Biol; 2004 Jun; 340(1):9-14. PubMed ID: 15184018
    [TBL] [Abstract][Full Text] [Related]  

  • 57. A novel fluorescence intensity screening assay identifies new low-molecular-weight inhibitors of the gp41 coiled-coil domain of human immunodeficiency virus type 1.
    Cai L; Gochin M
    Antimicrob Agents Chemother; 2007 Jul; 51(7):2388-95. PubMed ID: 17452484
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Mutations in the fusion peptide and heptad repeat regions of the Newcastle disease virus fusion protein block fusion.
    Sergel-Germano T; McQuain C; Morrison T
    J Virol; 1994 Nov; 68(11):7654-8. PubMed ID: 7933158
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Peptides derived from the heptad repeat region near the C-terminal of Sendai virus F protein bind the hemagglutinin-neuraminidase ectodomain.
    Tomasi M; Pasti C; Manfrinato C; Dallocchio F; Bellini T
    FEBS Lett; 2003 Feb; 536(1-3):56-60. PubMed ID: 12586338
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Two mutations in the HR2 region of Newcastle disease virus fusion protein with a cleavage motif "RRQRRL" are critical for fusogenic activity.
    Wang Y; Bi Y; Yu W; Wei N; Wang W; Wei Q; Wang X; Zhang S; Yang Z; Xiao S
    Virol J; 2017 Sep; 14(1):185. PubMed ID: 28946881
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.